• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于全骨髓测序的自噬相关特征鉴定用于多发性骨髓瘤的预后和免疫微环境特征分析。

Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma.

机构信息

Clinical Medical College, Guizhou Medical University, 550004 Guiyang, Guizhou Province, China.

Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guizhou Province Laboratory of Hematopoietic Stem Cell Transplantation Centre, 550004 Guiyang, Guizhou Province, China.

出版信息

J Immunol Res. 2022 May 29;2022:3922739. doi: 10.1155/2022/3922739. eCollection 2022.

DOI:10.1155/2022/3922739
PMID:35677537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9169202/
Abstract

Myeloma (MM) is a malignant plasma cell disorder, which is incurable owing to its drug resistance. Autophagy performs an integral function in homeostasis, survival, and drug resistance in multiple myeloma (MM). Therefore, the purpose of the present research was to identify potential autophagy-related genes (ARGs) in patients with MM. We downloaded the transcriptomic data (GSE136400) of patients with MM, as well as the corresponding clinical data from the Gene Expression Omnibus (GEO); the patients were classified at random into two groups in a ratio of 6: 4, with 212 samples in the training dataset and 142 samples in the test dataset. Both multivariate and univariate Cox regression analyses were performed to identify autophagy-related genes. The univariate Cox regression analysis demonstrated that 26 ARGs had a significant correlation with overall survival (OS). We constructed an autophagy-related risk prognostic model based on six ARGs: EIF2AK2 (ENSG00000055332), KIF5B (ENSG00000170759), MYC (ENSG00000136997), NRG2 (ENSG00000158458), PINK1 (ENSG00000158828), and VEGFA (ENSG00000112715) using LASSO-Cox regression analysis to predict risk outcomes, which revealed substantially shortened OS duration in the high-risk cohort in contrast with that in the low-risk cohort. Therefore, the ARG-based model significantly predicted the MM patients' prognoses and was verified in an internal test set. Differentially expressed genes were found to be predominantly enriched in pathways associated with inflammation and immune regulation. Immune infiltration of tumor cells resulted in the formation of a strong immunosuppressive microenvironment in high-risk patients. The potential therapeutic targets of ARGs were subsequently analyzed via protein-drug network analysis. Therefore, a prognostic model for MM was established via a comprehensive analysis of ARGs, through using the clinical models; we have further revealed the molecular landscape features of multiple myeloma.

摘要

骨髓瘤(MM)是一种恶性浆细胞疾病,由于其耐药性,该病无法治愈。自噬在多发性骨髓瘤(MM)的体内平衡、存活和耐药性中发挥着重要作用。因此,本研究旨在鉴定 MM 患者中潜在的自噬相关基因(ARGs)。我们从基因表达综合数据库(GEO)下载了 MM 患者的转录组数据(GSE136400)及其相应的临床数据;将患者随机分为两组,比例为 6:4,训练数据集有 212 个样本,测试数据集有 142 个样本。采用多变量和单变量 Cox 回归分析鉴定自噬相关基因。单变量 Cox 回归分析表明,26 个 ARG 与总生存期(OS)显著相关。我们基于 6 个 ARG 构建了一个自噬相关风险预后模型:EIF2AK2(ENSG00000055332)、KIF5B(ENSG00000170759)、MYC(ENSG00000136997)、NRG2(ENSG00000158458)、PINK1(ENSG00000158828)和 VEGFA(ENSG00000112715),使用 LASSO-Cox 回归分析预测风险结果,结果表明高危队列的 OS 明显缩短。因此,基于 ARG 的模型显著预测了 MM 患者的预后,并在内部测试集中得到验证。差异表达基因主要富集在与炎症和免疫调节相关的途径中。肿瘤细胞的免疫浸润导致高危患者形成强大的免疫抑制微环境。随后通过蛋白药物网络分析对 ARG 的潜在治疗靶点进行了分析。因此,通过综合分析 ARG,建立了 MM 的预后模型,进一步揭示了多发性骨髓瘤的分子特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/de3f80635579/JIR2022-3922739.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/b34d9259bfd6/JIR2022-3922739.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/459e9f43a3de/JIR2022-3922739.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/b17496620481/JIR2022-3922739.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/2ebf7f66eb10/JIR2022-3922739.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/4f3fb03c584b/JIR2022-3922739.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/4b6652c29e53/JIR2022-3922739.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/de3f80635579/JIR2022-3922739.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/b34d9259bfd6/JIR2022-3922739.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/459e9f43a3de/JIR2022-3922739.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/b17496620481/JIR2022-3922739.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/2ebf7f66eb10/JIR2022-3922739.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/4f3fb03c584b/JIR2022-3922739.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/4b6652c29e53/JIR2022-3922739.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e4d/9169202/de3f80635579/JIR2022-3922739.007.jpg

相似文献

1
Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma.基于全骨髓测序的自噬相关特征鉴定用于多发性骨髓瘤的预后和免疫微环境特征分析。
J Immunol Res. 2022 May 29;2022:3922739. doi: 10.1155/2022/3922739. eCollection 2022.
2
Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.通过鉴定自噬相关特征对急性髓系白血病免疫微环境的预后及特征分析
Front Immunol. 2021 May 31;12:695865. doi: 10.3389/fimmu.2021.695865. eCollection 2021.
3
A Four Autophagy-Related Gene-Based Prognostic Signature for Pancreatic Cancer.基于四个自噬相关基因的胰腺癌预后签名。
Crit Rev Eukaryot Gene Expr. 2021;31(4):89-100. doi: 10.1615/CritRevEukaryotGeneExpr.2021038733.
4
Construction and validation of a prognostic model of angiogenesis-related genes in multiple myeloma.构建并验证多发性骨髓瘤中与血管生成相关基因的预后模型。
BMC Cancer. 2024 Oct 11;24(1):1269. doi: 10.1186/s12885-024-13024-9.
5
Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.基于自噬相关基因的三阴性乳腺癌预后风险模型的构建与验证
Front Oncol. 2022 Feb 4;12:829045. doi: 10.3389/fonc.2022.829045. eCollection 2022.
6
Integrating Lysosomal Genes and Immune Infiltration for Multiple Myeloma Subtyping and Prognostic Stratification.整合溶酶体基因和免疫浸润对多发性骨髓瘤进行亚型分类和预后分层。
Folia Biol (Praha). 2024;70(2):85-94. doi: 10.14712/fb2024070020085.
7
[Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].[肺腺癌自噬相关基因预后风险评分模型的构建与验证]
Zhongguo Fei Ai Za Zhi. 2021 Aug 20;24(8):557-566. doi: 10.3779/j.issn.1009-3419.2021.103.09. Epub 2021 Jul 14.
8
Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma.整合分析自噬相关标志物对多发性骨髓瘤预后价值及其免疫微环境的影响。
BMC Cancer. 2023 Sep 12;23(1):859. doi: 10.1186/s12885-023-11371-7.
9
Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.基于自噬相关基因的头颈部鳞状细胞癌新型生存模型的建立和验证。
Genomics. 2021 Jan;113(1 Pt 2):1166-1175. doi: 10.1016/j.ygeno.2020.11.017. Epub 2020 Nov 20.
10
Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients.建立一个自噬相关基因表达谱,用于预测前列腺癌患者的预后。
J Transl Med. 2020 Apr 7;18(1):160. doi: 10.1186/s12967-020-02323-x.

引用本文的文献

1
Comprehensive genomic characterization of programmed cell death-related genes to predict drug resistance and prognosis for patients with multiple myeloma.对程序性细胞死亡相关基因进行全面基因组特征分析,以预测多发性骨髓瘤患者的耐药性和预后。
Aging (Albany NY). 2025 Apr 1;17(4):1043-1059. doi: 10.18632/aging.206234.
2
Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma.整合分析自噬相关标志物对多发性骨髓瘤预后价值及其免疫微环境的影响。
BMC Cancer. 2023 Sep 12;23(1):859. doi: 10.1186/s12885-023-11371-7.

本文引用的文献

1
Diagnosis and Management of Multiple Myeloma: A Review.多发性骨髓瘤的诊断与治疗:综述
JAMA. 2022 Feb 1;327(5):464-477. doi: 10.1001/jama.2022.0003.
2
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma.针对 LAG3/GAL-3 克服多发性骨髓瘤中的免疫抑制并增强抗肿瘤免疫反应。
Leukemia. 2022 Jan;36(1):138-154. doi: 10.1038/s41375-021-01301-6. Epub 2021 Jul 21.
3
Elongation factor eEF2 kinase and autophagy jointly promote survival of cancer cells.延伸因子 eEF2 激酶和自噬共同促进癌细胞的存活。
Biochem J. 2021 Apr 30;478(8):1547-1569. doi: 10.1042/BCJ20210126.
4
A Burned-Out CD8 T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy.耗竭的 CD8 T 细胞亚群在肿瘤微环境中扩增并抑制癌症免疫治疗。
Cancer Discov. 2021 Jul;11(7):1700-1715. doi: 10.1158/2159-8290.CD-20-0962. Epub 2021 Mar 3.
5
Mutant p53 as a Regulator and Target of Autophagy.突变型p53作为自噬的调节因子和靶点
Front Oncol. 2021 Feb 3;10:607149. doi: 10.3389/fonc.2020.607149. eCollection 2020.
6
Autophagy augments the self-renewal of lung cancer stem cells by the degradation of ubiquitinated p53.自噬通过降解泛素化的 p53 增强肺癌干细胞的自我更新。
Cell Death Dis. 2021 Jan 19;12(1):98. doi: 10.1038/s41419-021-03392-6.
7
A Prognostic Microenvironment-Related Immune Signature ESTIMATE (PROMISE Model) Predicts Overall Survival of Patients With Glioma.一种与预后微环境相关的免疫特征——ESTIMATE(预后微环境相关免疫特征预测模型)预测胶质瘤患者的总生存期。
Front Oncol. 2020 Dec 7;10:580263. doi: 10.3389/fonc.2020.580263. eCollection 2020.
8
Targeting Casein Kinase 1 (CK1) in Hematological Cancers.靶向血液系统恶性肿瘤中的酪蛋白激酶 1(CK1)。
Int J Mol Sci. 2020 Nov 27;21(23):9026. doi: 10.3390/ijms21239026.
9
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance.免疫检查点抑制剂在癌症治疗中的应用:临床影响及反应和耐药的机制。
Annu Rev Pathol. 2021 Jan 24;16:223-249. doi: 10.1146/annurev-pathol-042020-042741. Epub 2020 Nov 16.
10
An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.一种与胶质瘤临床预后和免疫微环境相关的自噬相关基因特征
Front Oncol. 2020 Oct 19;10:571189. doi: 10.3389/fonc.2020.571189. eCollection 2020.